工程反应性氧物种 (ROS) -响应性人工H+/Cl-离子通道用于向癌症治疗
Chunyan Jia1,2, Daoxin Luo1,2, Jin Zhou1
1State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, School of Pharmaceutical Sciences, Xiamen University Xiamen, Fujian 361102, China.
研究人员开发了新型的人工离子通道,可以在癌细胞中激活反应性氧物种 (ROS). 这些ROS响应道显示出强有力的和选择性的癌细胞亡,提供了一种新的治疗策略.
科学领域:
- 生物化学和分子生物学
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 响应活性氧物种 (ROS) 的离子通道对于细胞适应氧化应激至关重要.
- 人工复制ROS响应性离子通道功能仍然是一个重大挑战.
- 癌细胞表现出改变的氧化还原状态和升高的ROS水平.
研究的目的:
- 设计和合成一种新型的人工离子通道类型,能够响应高ROS水平.
- 研究这些人工通道的自我组装机制和离子传输特性.
- 评估ROS响应道对癌细胞的治疗潜力和选择性.
主要方法:
- 通过ROS诱导的脱落而激活的人造H+/Cl-离子通道的开发.
- 调查道自组装到H键级流中的情况.
- 在人类乳腺癌细胞中评估H+/Cl-离子运输选择性和亡活性.
主要成果:
- 一种新型的人工H+/Cl-离子通道 (ROS-C-Cl) 被ROS成功合成并激活.
- ROS-C-Cl自组装成功能级联,其H+/Cl-离子运输选择性为7.7.
- ROS-C-Cl对人类乳腺癌细胞 (IC50 = 2.8 μM) 具有显著的亡活性,具有很高的选择性 (SI = 10.2).
结论:
- 可以有效地设计和合成可响应ROS的人工H+/Cl-离子通道.
- 通过利用瘤的氧化微环境,ROS-C-Cl表现出强有力的和选择性的抗癌活性.
- 这种新的方法为向癌症治疗提供了一个有希望的策略.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
